AbbVie buys Apogee for $10.9bn to acquire inflammatory disease drug
- Posted on June 22, 2026
- By Financial Times
- 0 Views
- 1 min read
AbbVie buys Apogee for $10.9bn to acquire inflammatory disease drug
Drugmaker’s largest deal in more than half a decade comes amid surge of M&A in sector
